XML 37 R24.htm IDEA: XBRL DOCUMENT v3.22.1
SHARE-BASED COMPENSATION PLANS (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Outstanding Awards
At December 31, 2021 and 2020, outstanding awards were comprised of the following:
December 31, 2021
December 31, 2020
Options2,074,858 1,425,207 
Inducement option awards65,760 85,761 
Restricted stock units137,004 129,361 
Inducement restricted stock units500 500 
Total outstanding awards2,278,122 1,640,829 
Weighted-Average Valuation Assumptions
The fair value of the option grants has been estimated, with the following weighted-average assumptions:
Year Ended
December 31, 2021December 31, 2020
Options granted1,023,000 1,352,595 
Weighted-average exercise price2.80 7.59 
Weighted-average grant date fair value2.02 5.29 
Assumptions:
Risk-free interest rate0.92 %0.82 %
Volatility90 %85 %
Expected life (years)5.635.83
Expected dividend yield— — 
Schedule of Stock Option Activity
The following table summarizes the stock option activity for all stock plans during the year ended December 31, 2021 and 2020 as follows:
OptionsOutstanding Stock OptionsWeighted Average Exercise Price
Weighted Average Remaining Contractual Term (in years)
Aggregate Intrinsic Value
(in thousands)
Balance at December 31, 2019
567,842 $76.25 7.82$12 
Granted1,352,595 $7.59 
Exercised— 
Forfeited(409,469)$29.86 
Balance at December 31, 2020
1,510,968 $27.36 8.19$379 
Granted1,023,000 $2.80 
Exercised— 
Forfeited(393,350)$30.66 
Balance at December 31, 2021
2,140,618 $15.01 8.48$— 
Exercisable at December 31, 2021
718,123 $36.42 6.98$— 
Summary of Options Outstanding and Exercisable
The following table summarizes the options outstanding and exercisable at December 31, 2021:
Options OutstandingOptions Exercisable
Exercise PriceTotal Shares
Weighted Average Remaining Contractual Term
(in years)
Weighted Average Exercise PriceTotal Shares
Weighted Average Remaining Contractual Term
(in years)
Weighted Average Exercise Price
$1.73 to $2.87
215,000 9.89$1.81 — 0.00$— 
$2.88 to $2.93
665,000 9.62$2.88 — 0.00$— 
$2.94 to $3.01
506,000 8.95$2.97 253,000 8.95$2.97 
$3.02 to $16.15
475,076 7.32$9.97 207,374 6.15$11.97 
$16.16 to $234.70
279,542 5.82$84.39 257,749 5.71$88.94 
Total2,140,618 8.48$15.01 718,123 6.98$36.42 
Schedule of Restricted Stock Unit Activity
The following table summarizes the stock award activity for all restricted stock units during the year ended December 31, 2021:
AwardsOutstanding Restricted Stock Awards and UnitsWeighted-Average Grant Date Fair Value Per ShareOutstanding Aggregate Intrinsic Value (in thousands)Total Fair Value of Restricted Awards Vested (in thousands)
Balance at December 31, 2019
6,359 $92.29 $82 
Granted239,023 $4.70 
Vested(2,309)$96.14 $30 $222 
Forfeited(113,212)$6.73 
Balance at December 31, 2020
129,861 $5.59 $458 
Granted136,626 $3.54 
Vested(126,477)$5.05 $413 $659 
Forfeited(2,506)$4.85 
Balance at December 31, 2021
137,504 $4.06 $205 
Summary of ESPP Activity
A summary of activity within the ESPP follows:
Year Ended
(in thousands except share data)December 31, 2021December 31, 2020
Deductions from employees$— $56 
Share-based compensation expense recognized$— $96 
Proceeds received by the Company for ESPP$— $78 
Weighted-average purchase price per common share $— $5.21 
Schedule Share-based Compensation
Share-based compensation expense by classification for December 31, 2021 and 2020 are as follows:
Year Ended
(in thousands)December 31, 2021December 31, 2020
General and administrative$2,275 $3,170 
Research and development1,164 1,861 
     Total$3,439 $5,031